25 XP   0   0   10

Henan Taloph Pharmaceutical Stock Co Ltd
Buy, Hold or Sell?

Let's analyse Taloph together

PenkeI guess you are interested in Henan Taloph Pharmaceutical Stock Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Henan Taloph Pharmaceutical Stock Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Henan Taloph Pharmaceutical Stock Co Ltd

I send you an email if I find something interesting about Henan Taloph Pharmaceutical Stock Co Ltd.

Quick analysis of Taloph (30 sec.)










What can you expect buying and holding a share of Taloph? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
¥2.83
Expected worth in 1 year
¥2.85
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥0.07
Return On Investment
1.3%

For what price can you sell your share?

Current Price per Share
¥5.05
Expected price per share
¥3.75 - ¥5.75
How sure are you?
50%

1. Valuation of Taloph (5 min.)




Live pricePrice per Share (EOD)

¥5.05

Intrinsic Value Per Share

¥3.64 - ¥4.42

Total Value Per Share

¥6.47 - ¥7.24

2. Growth of Taloph (5 min.)




Is Taloph growing?

Current yearPrevious yearGrowGrow %
How rich?$224m$239.2m-$26.4m-12.4%

How much money is Taloph making?

Current yearPrevious yearGrowGrow %
Making money$1.5m-$2.4m$3.9m265.6%
Net Profit Margin1.3%-3.8%--

How much money comes from the company's main activities?

3. Financial Health of Taloph (5 min.)




What can you expect buying and holding a share of Taloph? (5 min.)

Welcome investor! Taloph's management wants to use your money to grow the business. In return you get a share of Taloph.

What can you expect buying and holding a share of Taloph?

First you should know what it really means to hold a share of Taloph. And how you can make/lose money.

Speculation

The Price per Share of Taloph is ¥5.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Taloph.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Taloph, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.83. Based on the TTM, the Book Value Change Per Share is ¥0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Taloph.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.3%0.000.0%0.00-0.1%0.000.0%0.000.0%
Usd Book Value Change Per Share0.030.6%0.000.0%-0.01-0.2%0.000.1%0.000.1%
Usd Dividend Per Share0.000.1%0.000.0%0.000.1%0.000.1%0.010.1%
Usd Total Gains Per Share0.040.7%0.000.0%-0.01-0.1%0.010.1%0.010.2%
Usd Price Per Share0.85-0.81-0.88-0.83-0.88-
Price to Earnings Ratio14.54-2.97-94.62-122.44-507.61-
Price-to-Total Gains Ratio23.63--30.93-147.69-64.86-329.18-
Price to Book Ratio2.17-2.19-2.10-2.22-2.47-
Price-to-Total Gains Ratio23.63--30.93-147.69-64.86-329.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6969
Number of shares1434
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (1434 shares)3.308.86
Gains per Year (1434 shares)13.2135.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11033191625
220616393260
3301029584895
44013427864130
55016559780165
660196811796200
7702381136112235
8802694156128270
99029107175144305
1010032120194160340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%12.08.00.060.0%29.09.02.072.5%76.09.03.086.4%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%11.09.00.055.0%24.016.00.060.0%69.019.00.078.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.00.02.095.0%67.00.021.076.1%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%13.07.00.065.0%32.08.00.080.0%78.010.00.088.6%

Fundamentals of Taloph

About Henan Taloph Pharmaceutical Stock Co Ltd

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of Chinese medicines in China. The company primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and others. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, Xiaoer Qingre Zhike oral liquid, pediatric compound Ji Neijin chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1993 and is based in Zhengzhou, China.

Fundamental data was last updated by Penke on 2024-04-17 06:08:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Henan Taloph Pharmaceutical Stock Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Taloph earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.6% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 9.6%. The company is making a profit. +1
  • The TTM is 1.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.6%TTM1.3%+8.3%
TTM1.3%YOY-3.8%+5.2%
TTM1.3%5Y0.6%+0.7%
5Y0.6%10Y-0.1%+0.7%
1.1.2. Return on Assets

Shows how efficient Taloph is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.7% Return on Assets means that Taloph generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM0.3%+1.4%
TTM0.3%YOY-0.5%+0.8%
TTM0.3%5Y0.1%+0.2%
5Y0.1%10Y0.0%+0.1%
1.1.3. Return on Equity

Shows how efficient Taloph is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.8% Return on Equity means Taloph generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 3.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM0.6%+3.2%
TTM0.6%YOY-1.1%+1.8%
TTM0.6%5Y0.2%+0.4%
5Y0.2%10Y0.0%+0.2%

1.2. Operating Efficiency of Henan Taloph Pharmaceutical Stock Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Taloph is operating .

  • Measures how much profit Taloph makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2.3%+2.3%
TTM-2.3%YOY1.1%-3.4%
TTM-2.3%5Y3.9%-6.2%
5Y3.9%10Y2.3%+1.6%
1.2.2. Operating Ratio

Measures how efficient Taloph is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.54 means that the operating costs are ¥1.54 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.537. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.690. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.537TTM1.690-0.152
TTM1.690YOY1.739-0.049
TTM1.6905Y1.645+0.045
5Y1.64510Y1.239+0.406

1.3. Liquidity of Henan Taloph Pharmaceutical Stock Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Taloph is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.21 means the company has ¥1.21 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.208. The company is just able to pay all its short-term debts.
  • The TTM is 1.088. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.208TTM1.088+0.120
TTM1.088YOY1.168-0.081
TTM1.0885Y1.410-0.323
5Y1.41010Y0.851+0.560
1.3.2. Quick Ratio

Measures if Taloph is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.54 means the company can pay off ¥0.54 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.541. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.502. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.541TTM0.502+0.039
TTM0.502YOY0.627-0.125
TTM0.5025Y0.690-0.188
5Y0.69010Y0.706-0.016

1.4. Solvency of Henan Taloph Pharmaceutical Stock Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Taloph assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Taloph to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55 means that Taloph assets are financed with 54.6% credit (debt) and the remaining percentage (100% - 54.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.546. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.556. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.546TTM0.556-0.010
TTM0.556YOY0.521+0.035
TTM0.5565Y0.528+0.027
5Y0.52810Y0.491+0.037
1.4.2. Debt to Equity Ratio

Measures if Taloph is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 123.8% means that company has ¥1.24 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.238. The company is able to pay all its debts with equity. +1
  • The TTM is 1.287. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.238TTM1.287-0.050
TTM1.287YOY1.155+0.132
TTM1.2875Y1.163+0.124
5Y1.16310Y1.010+0.154

2. Market Valuation of Henan Taloph Pharmaceutical Stock Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Taloph generates.

  • Above 15 is considered overpriced but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 14.54 means the investor is paying ¥14.54 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 11.979. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.541. Based on the earnings, the company is underpriced. +1
  • The TTM is 2.971. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.979MRQ14.541-2.562
MRQ14.541TTM2.971+11.570
TTM2.971YOY94.622-91.651
TTM2.9715Y122.439-119.468
5Y122.43910Y507.607-385.168
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 8.743. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.612. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -45.985. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.743MRQ10.612-1.870
MRQ10.612TTM-45.985+56.598
TTM-45.985YOY-15.856-30.130
TTM-45.9855Y-32.610-13.375
5Y-32.61010Y-4.845-27.765
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Taloph is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 1.785. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.167. Based on the equity, the company is underpriced. +1
  • The TTM is 2.185. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.785MRQ2.167-0.382
MRQ2.167TTM2.185-0.018
TTM2.185YOY2.102+0.083
TTM2.1855Y2.218-0.033
5Y2.21810Y2.466-0.248
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Henan Taloph Pharmaceutical Stock Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2290.004+5523%-0.071+131%0.020+1032%0.023+890%
Book Value Per Share--2.8292.688+5%3.022-6%2.713+4%2.598+9%
Current Ratio--1.2081.088+11%1.168+3%1.410-14%0.851+42%
Debt To Asset Ratio--0.5460.556-2%0.521+5%0.528+3%0.491+11%
Debt To Equity Ratio--1.2381.287-4%1.155+7%1.163+6%1.010+23%
Dividend Per Share--0.0300.013+141%0.019+63%0.025+24%0.038-21%
Eps--0.105-0.001+101%-0.031+130%0.001+18042%-0.002+102%
Free Cash Flow Per Share--0.1440.000+54753%-0.083+158%-0.017+112%-0.005+103%
Free Cash Flow To Equity Per Share--0.144-0.014+109%-0.129+189%-0.045+131%0.013+1014%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Intrinsic Value_10Y_max--4.415--------
Intrinsic Value_10Y_min--3.637--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.336--------
Intrinsic Value_3Y_min--0.314--------
Intrinsic Value_5Y_max--1.080--------
Intrinsic Value_5Y_min--0.973--------
Market Cap2898124380.800-21%3517922914.7903367277765.503+4%3657090338.418-4%3455942996.777+2%3665841102.917-4%
Net Profit Margin--0.0960.013+617%-0.038+140%0.006+1471%-0.001+101%
Operating Margin----0.0230%0.011-100%0.039-100%0.023-100%
Operating Ratio--1.5371.690-9%1.739-12%1.645-7%1.239+24%
Pb Ratio1.785-21%2.1672.185-1%2.102+3%2.218-2%2.466-12%
Pe Ratio11.979-21%14.5412.971+389%94.622-85%122.439-88%507.607-97%
Price Per Share5.050-21%6.1305.868+4%6.373-4%6.022+2%6.388-4%
Price To Free Cash Flow Ratio8.743-21%10.612-45.985+533%-15.856+249%-32.610+407%-4.845+146%
Price To Total Gains Ratio19.463-21%23.626-30.926+231%147.687-84%64.860-64%329.182-93%
Quick Ratio--0.5410.502+8%0.627-14%0.690-22%0.706-23%
Return On Assets--0.0170.003+465%-0.005+130%0.001+1543%0.000+25056%
Return On Equity--0.0380.006+493%-0.011+129%0.002+1801%0.000+55414%
Total Gains Per Share--0.2590.017+1454%-0.053+120%0.045+479%0.062+321%
Usd Book Value--224027615.349212862210.848+5%239295905.410-6%214845171.340+4%205732833.139+9%
Usd Book Value Change Per Share--0.0320.001+5523%-0.010+131%0.003+1032%0.003+890%
Usd Book Value Per Share--0.3900.371+5%0.417-6%0.374+4%0.358+9%
Usd Dividend Per Share--0.0040.002+141%0.003+63%0.003+24%0.005-21%
Usd Eps--0.0150.000+101%-0.004+130%0.000+18042%0.000+102%
Usd Free Cash Flow--11436655.73420849.735+54753%-6590502.643+158%-1332002.977+112%-299292.722+103%
Usd Free Cash Flow Per Share--0.0200.000+54753%-0.011+158%-0.002+112%-0.001+103%
Usd Free Cash Flow To Equity Per Share--0.020-0.002+109%-0.018+189%-0.006+131%0.002+1014%
Usd Market Cap399941164.550-21%485473362.241464684331.639+4%504678466.702-4%476920133.555+2%505886072.202-4%
Usd Price Per Share0.697-21%0.8460.810+4%0.879-4%0.831+2%0.882-4%
Usd Profit--8346664.5631502707.005+455%-2488837.403+130%361315.989+2210%-30860.070+100%
Usd Revenue--86531397.72671411851.411+21%67643953.675+28%57711821.597+50%48134864.472+80%
Usd Total Gains Per Share--0.0360.002+1454%-0.007+120%0.006+479%0.009+321%
 EOD+4 -4MRQTTM+31 -3YOY+22 -135Y+27 -810Y+24 -12

3.2. Fundamental Score

Let's check the fundamental score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.979
Price to Book Ratio (EOD)Between0-11.785
Net Profit Margin (MRQ)Greater than00.096
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.541
Current Ratio (MRQ)Greater than11.208
Debt to Asset Ratio (MRQ)Less than10.546
Debt to Equity Ratio (MRQ)Less than11.238
Return on Equity (MRQ)Greater than0.150.038
Return on Assets (MRQ)Greater than0.050.017
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.159
Ma 20Greater thanMa 505.169
Ma 50Greater thanMa 1005.031
Ma 100Greater thanMa 2005.503
OpenGreater thanClose4.950
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,576,855
Total Liabilities1,953,466
Total Stockholder Equity1,578,494
 As reported
Total Liabilities 1,953,466
Total Stockholder Equity+ 1,578,494
Total Assets = 3,576,855

Assets

Total Assets3,576,855
Total Current Assets1,993,074
Long-term Assets1,583,781
Total Current Assets
Cash And Cash Equivalents 196,666
Short-term Investments 153,300
Net Receivables 739,637
Inventory 455,500
Other Current Assets 16,353
Total Current Assets  (as reported)1,993,074
Total Current Assets  (calculated)1,561,455
+/- 431,619
Long-term Assets
Property Plant Equipment 529,652
Goodwill 286,493
Intangible Assets 77,197
Long-term Assets Other 48,088
Long-term Assets  (as reported)1,583,781
Long-term Assets  (calculated)941,430
+/- 642,352

Liabilities & Shareholders' Equity

Total Current Liabilities1,650,148
Long-term Liabilities303,318
Total Stockholder Equity1,578,494
Total Current Liabilities
Short Long Term Debt 381,838
Accounts payable 470,286
Other Current Liabilities 5,520
Total Current Liabilities  (as reported)1,650,148
Total Current Liabilities  (calculated)857,644
+/- 792,504
Long-term Liabilities
Long term Debt 183,800
Capital Lease Obligations Min Short Term Debt19,286
Long-term Liabilities Other 1,615
Long-term Liabilities  (as reported)303,318
Long-term Liabilities  (calculated)204,701
+/- 98,618
Total Stockholder Equity
Retained Earnings 230,105
Total Stockholder Equity (as reported)1,578,494
Total Stockholder Equity (calculated)230,105
+/- 1,348,389
Other
Capital Stock573,886
Common Stock Shares Outstanding 573,886
Net Debt 368,972
Net Invested Capital 2,144,132
Net Working Capital 342,925
Property Plant and Equipment Gross 529,652



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
549,580
566,837
541,669
622,909
618,929
613,180
611,588
692,995
682,744
707,222
690,994
708,968
715,849
709,212
704,569
739,113
780,177
743,244
748,858
750,660
818,344
822,920
864,759
809,289
818,250
801,622
836,620
844,861
893,549
963,921
1,008,602
936,401
1,010,835
1,069,901
1,132,515
1,092,164
1,179,695
1,243,668
1,248,308
1,251,240
1,304,163
1,406,401
1,431,925
1,460,168
1,479,968
1,511,851
1,498,168
1,569,436
1,584,327
1,608,559
1,999,902
1,953,624
2,117,736
2,157,448
2,125,469
2,291,707
2,610,776
2,665,002
2,667,767
2,639,558
2,664,269
2,711,658
2,744,120
2,650,827
2,692,787
2,703,038
2,740,508
2,808,177
2,833,192
2,746,537
2,717,069
2,835,342
2,767,464
2,625,179
2,618,953
2,739,423
2,815,740
2,784,213
3,023,968
3,389,395
3,739,252
3,655,836
3,857,651
3,783,772
3,789,529
3,532,867
3,541,531
3,606,600
3,572,513
3,395,367
3,339,323
3,576,855
3,576,8553,339,3233,395,3673,572,5133,606,6003,541,5313,532,8673,789,5293,783,7723,857,6513,655,8363,739,2523,389,3953,023,9682,784,2132,815,7402,739,4232,618,9532,625,1792,767,4642,835,3422,717,0692,746,5372,833,1922,808,1772,740,5082,703,0382,692,7872,650,8272,744,1202,711,6582,664,2692,639,5582,667,7672,665,0022,610,7762,291,7072,125,4692,157,4482,117,7361,953,6241,999,9021,608,5591,584,3271,569,4361,498,1681,511,8511,479,9681,460,1681,431,9251,406,4011,304,1631,251,2401,248,3081,243,6681,179,6951,092,1641,132,5151,069,9011,010,835936,4011,008,602963,921893,549844,861836,620801,622818,250809,289864,759822,920818,344750,660748,858743,244780,177739,113704,569709,212715,849708,968690,994707,222682,744692,995611,588613,180618,929622,909541,669566,837549,580
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,522,893
1,513,401
1,722,834
1,635,028
1,603,733
1,601,900
1,726,827
1,775,735
1,706,777
1,866,119
1,882,375
1,937,217
1,829,650
2,108,606
1,943,707
1,962,212
1,721,081
1,942,084
2,031,240
1,982,901
1,863,188
1,836,730
1,993,074
1,993,0741,836,7301,863,1881,982,9012,031,2401,942,0841,721,0811,962,2121,943,7072,108,6061,829,6501,937,2171,882,3751,866,1191,706,7771,775,7351,726,8271,601,9001,603,7331,635,0281,722,8341,513,4011,522,893000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
587,234
572,791
670,108
664,951
386,460
392,355
398,091
459,493
395,576
463,363
487,316
493,685
380,397
571,223
380,549
264,428
161,813
373,983
311,384
248,462
196,151
181,546
196,666
196,666181,546196,151248,462311,384373,983161,813264,428380,549571,223380,397493,685487,316463,363395,576459,493398,091392,355386,460664,951670,108572,791587,234000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,500
7,000
99,400
10,100
176,400
137,850
161,440
160,640
207,460
167,070
171,400
203,950
285,667
211,800
93,329
68,069
74,956
30,236
64,326
62,579
153,300
153,30062,57964,32630,23674,95668,06993,329211,800285,667203,950171,400167,070207,460160,640161,440137,850176,40010,10099,4007,000115,50000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
131,525
111,652
113,970
124,402
136,524
145,332
149,697
179,481
177,093
195,470
184,383
221,986
204,402
215,724
202,380
226,205
244,966
210,254
178,693
173,384
184,458
189,082
242,250
206,617
211,756
201,547
206,148
207,500
227,525
217,698
230,350
197,692
229,215
253,775
254,344
253,798
293,160
285,623
291,714
326,900
352,836
349,267
366,689
376,029
387,236
449,941
428,295
431,222
466,393
457,738
462,049
551,892
648,861
603,696
593,778
511,592
568,851
546,549
537,273
473,283
493,697
497,356
511,079
451,940
556,317
554,187
549,673
572,338
655,673
594,630
604,433
571,184
445,888
476,599
512,912
779,245
803,011
774,802
888,183
767,892
859,010
865,913
817,322
801,149
936,733
971,800
1,023,056
709,294
744,736
1,043,408
704,303
739,637
739,637704,3031,043,408744,736709,2941,023,056971,800936,733801,149817,322865,913859,010767,892888,183774,802803,011779,245512,912476,599445,888571,184604,433594,630655,673572,338549,673554,187556,317451,940511,079497,356493,697473,283537,273546,549568,851511,592593,778603,696648,861551,892462,049457,738466,393431,222428,295449,941387,236376,029366,689349,267352,836326,900291,714285,623293,160253,798254,344253,775229,215197,692230,350217,698227,525207,500206,148201,547211,756206,617242,250189,082184,458173,384178,693210,254244,966226,205202,380215,724204,402221,986184,383195,470177,093179,481149,697145,332136,524124,402113,970111,652131,525
       Other Current Assets 
1,319
2,096
838
741
883
1,327
749
11,863
16,505
19,349
20,485
2,523
11,882
3,028
2,532
7,322
2,017
2,981
2,909
12,642
10,568
9,490
10,316
11,140
13,643
11,925
10,258
9,734
15,903
12,031
13,863
12,574
14,619
23,479
29,179
20,984
24,423
17,604
22,738
17,444
21,616
17,342
21,453
42,668
19,918
24,342
25,983
56,689
29,245
43,576
43,057
28,535
36,009
20,852
84,563
29,048
89,846
39,612
47,245
36,073
68,196
48,590
47,206
55,994
52,009
65,273
59,616
70,086
69,354
77,397
84,449
70,267
10,679
10,741
10,986
73,142
82,847
76,761
70,582
71,563
67,055
66,642
111,544
94,494
124,459
124,892
106,100
8,174
16,300
103,828
17,240
16,353
16,35317,240103,82816,3008,174106,100124,892124,45994,494111,54466,64267,05571,56370,58276,76182,84773,14210,98610,74110,67970,26784,44977,39769,35470,08659,61665,27352,00955,99447,20648,59068,19636,07347,24539,61289,84629,04884,56320,85236,00928,53543,05743,57629,24556,68925,98324,34219,91842,66821,45317,34221,61617,44422,73817,60424,42320,98429,17923,47914,61912,57413,86312,03115,9039,73410,25811,92513,64311,14010,3169,49010,56812,6422,9092,9812,0177,3222,5323,02811,8822,52320,48519,34916,50511,8637491,3278837418382,0961,319
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,132,436
1,021,446
1,017,053
1,012,596
1,040,005
1,077,436
1,157,850
1,507,020
1,802,035
1,826,186
1,749,045
1,840,065
1,827,317
1,811,787
1,599,447
1,575,359
1,589,611
1,532,179
1,502,593
1,583,781
1,583,7811,502,5931,532,1791,589,6111,575,3591,599,4471,811,7871,827,3171,840,0651,749,0451,826,1861,802,0351,507,0201,157,8501,077,4361,040,0051,012,5961,017,0531,021,4461,132,436000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
135,968
227,632
259,179
276,731
275,763
274,290
275,078
276,691
278,450
282,425
279,582
278,119
285,196
281,374
302,253
298,759
295,631
307,042
303,667
345,002
331,020
342,677
352,043
365,480
350,610
366,705
373,046
425,323
416,804
463,944
466,964
502,886
497,599
511,421
520,272
560,448
551,312
590,021
573,606
606,236
609,051
645,545
579,151
704,038
634,049
701,852
645,709
707,598
635,827
695,032
625,503
687,640
615,024
649,090
659,979
664,551
664,508
678,228
674,037
715,948
711,461
711,937
715,529
710,252
626,431
622,129
618,089
614,713
619,730
615,973
613,129
481,958
491,448
429,542
427,605
447,984
454,512
471,709
469,793
494,089
532,198
526,041
533,157
539,585
535,612
533,985
538,859
551,133
537,912
538,586
527,998
529,652
529,652527,998538,586537,912551,133538,859533,985535,612539,585533,157526,041532,198494,089469,793471,709454,512447,984427,605429,542491,448481,958613,129615,973619,730614,713618,089622,129626,431710,252715,529711,937711,461715,948674,037678,228664,508664,551659,979649,090615,024687,640625,503695,032635,827707,598645,709701,852634,049704,038579,151645,545609,051606,236573,606590,021551,312560,448520,272511,421497,599502,886466,964463,944416,804425,323373,046366,705350,610365,480352,043342,677331,020345,002303,667307,042295,631298,759302,253281,374285,196278,119279,582282,425278,450276,691275,078274,290275,763276,731259,179227,632135,968
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
842
891
842
891
284,789
283,634
283,634
286,391
286,391
286,391
286,391
287,334
287,334
287,334
287,334
286,527
286,527
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493
286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,493286,527286,527287,334287,334287,334287,334286,391286,391286,391286,391283,634283,634284,7898918428918420000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120,135
120,167
139,775
150,480
140,325
137,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000137,756140,325150,480139,775120,167120,135000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
15,957
15,774
15,591
16,158
16,047
15,937
15,827
16,628
16,477
16,326
16,175
16,024
15,873
15,721
15,570
15,419
15,268
1,004
14,966
883
14,663
762
32,361
17,741
30,784
16,737
29,581
15,699
29,529
15,231
28,346
14,243
27,373
13,275
26,840
12,295
28,738
11,328
35,612
10,362
35,073
11,208
95,690
9,829
95,598
8,830
96,516
7,832
103,299
13,322
105,762
12,185
77,654
85,017
84,022
84,151
370,516
364,669
363,470
391,064
389,773
415,591
414,194
413,379
411,867
410,411
408,858
406,819
405,351
117,305
115,778
114,086
131,903
42,239
82,734
81,442
80,162
78,933
77,751
76,862
75,773
74,685
73,629
72,840
72,123
76,895
77,249
76,059
76,502
77,331
82,473
77,197
77,19782,47377,33176,50276,05977,24976,89572,12372,84073,62974,68575,77376,86277,75178,93380,16281,44282,73442,239131,903114,086115,778117,305405,351406,819408,858410,411411,867413,379414,194415,591389,773391,064363,470364,669370,51684,15184,02285,01777,65412,185105,76213,322103,2997,83296,5168,83095,5989,82995,69011,20835,07310,36235,61211,32828,73812,29526,84013,27527,37314,24328,34615,23129,52915,69929,58116,73730,78417,74132,36176214,66388314,9661,00415,26815,41915,57015,72115,87316,02416,17516,32616,47716,62815,82715,93716,04716,15815,59115,77415,957
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,428
85,054
30,030
50,319
64,619
45,519
515,311
54,990
45,519
45,519
45,519
47,054
45,519
58,500
48,235
46,355
49,171
50,783
53,617
48,088
48,08853,61750,78349,17146,35548,23558,50045,51947,05445,51945,51945,51954,990515,31145,51964,61950,31930,03085,05481,428000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
137,564
162,449
121,281
206,073
196,632
190,682
188,088
264,701
250,903
273,396
257,412
268,356
274,202
266,405
262,064
283,437
320,445
282,303
281,546
278,696
344,482
344,645
385,398
322,243
324,579
298,222
330,646
323,294
359,342
418,743
459,612
381,430
452,761
500,923
556,588
506,123
588,139
645,626
643,200
641,917
691,463
787,479
813,707
831,281
845,791
873,271
857,986
912,934
920,287
932,500
930,012
861,222
1,013,454
1,006,008
974,816
1,105,550
1,105,053
1,165,835
1,169,009
1,140,159
1,164,173
1,212,147
1,245,418
1,150,861
1,190,223
1,199,068
1,236,330
1,299,932
1,323,565
1,257,049
1,224,474
1,444,138
1,426,160
1,312,378
1,309,656
1,427,621
1,466,939
1,444,473
1,600,878
1,858,824
1,935,821
1,847,168
2,133,845
2,006,136
1,884,367
1,724,128
1,933,360
1,992,560
1,975,922
1,937,398
1,847,352
1,953,466
1,953,4661,847,3521,937,3981,975,9221,992,5601,933,3601,724,1281,884,3672,006,1362,133,8451,847,1681,935,8211,858,8241,600,8781,444,4731,466,9391,427,6211,309,6561,312,3781,426,1601,444,1381,224,4741,257,0491,323,5651,299,9321,236,3301,199,0681,190,2231,150,8611,245,4181,212,1471,164,1731,140,1591,169,0091,165,8351,105,0531,105,550974,8161,006,0081,013,454861,222930,012932,500920,287912,934857,986873,271845,791831,281813,707787,479691,463641,917643,200645,626588,139506,123556,588500,923452,761381,430459,612418,743359,342323,294330,646298,222324,579322,243385,398344,645344,482278,696281,546282,303320,445283,437262,064266,405274,202268,356257,412273,396250,903264,701188,088190,682196,632206,073121,281162,449137,564
   > Total Current Liabilities 
133,644
159,009
121,281
206,073
196,632
190,681
187,188
263,800
250,004
272,496
256,512
268,357
274,202
266,405
262,064
283,437
320,445
282,303
281,546
278,696
344,482
344,645
385,398
322,243
324,579
298,222
330,645
323,294
359,342
418,599
459,579
381,430
422,734
480,116
538,443
483,353
567,964
628,168
613,219
579,148
565,279
624,174
632,883
597,227
570,746
590,863
584,062
649,982
663,594
690,493
697,451
657,274
817,186
826,917
803,319
960,075
965,159
1,055,219
1,058,409
1,037,142
1,061,157
669,156
596,431
582,273
587,636
602,481
639,821
707,742
731,516
677,600
645,045
1,404,118
1,381,610
859,160
763,660
892,470
913,095
901,616
881,663
1,503,881
1,483,177
1,484,055
1,794,135
1,649,676
1,670,647
1,550,906
1,602,430
1,726,028
1,907,173
1,798,669
1,721,354
1,650,148
1,650,1481,721,3541,798,6691,907,1731,726,0281,602,4301,550,9061,670,6471,649,6761,794,1351,484,0551,483,1771,503,881881,663901,616913,095892,470763,660859,1601,381,6101,404,118645,045677,600731,516707,742639,821602,481587,636582,273596,431669,1561,061,1571,037,1421,058,4091,055,219965,159960,075803,319826,917817,186657,274697,451690,493663,594649,982584,062590,863570,746597,227632,883624,174565,279579,148613,219628,168567,964483,353538,443480,116422,734381,430459,579418,599359,342323,294330,645298,222324,579322,243385,398344,645344,482278,696281,546282,303320,445283,437262,064266,405274,202268,357256,512272,496250,004263,800187,188190,681196,632206,073121,281159,009133,644
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
541,000
667,121
640,050
524,000
574,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000574,900524,000640,050667,121541,00000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
541,000
667,121
640,050
524,000
574,900
609,079
615,884
559,602
750,215
750,537
961,996
1,090,470
973,579
974,047
461,547
372,200
404,867
452,836
454,844
406,819
381,838
381,838406,819454,844452,836404,867372,200461,547974,047973,5791,090,470961,996750,537750,215559,602615,884609,079574,900524,000640,050667,121541,00000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
28,452
21,275
23,695
37,575
43,980
40,864
43,443
55,262
59,002
58,763
63,567
53,868
52,430
50,372
51,782
62,521
86,441
52,314
52,341
50,805
76,622
79,870
83,342
95,516
93,512
87,572
81,866
72,299
105,410
166,162
197,854
107,012
129,318
146,748
180,234
142,602
230,041
265,535
228,732
163,002
203,143
191,813
185,293
163,930
182,811
227,271
190,461
207,033
197,233
275,216
262,480
183,437
295,538
239,428
213,810
157,063
147,387
171,901
184,227
129,054
130,500
143,254
146,915
105,686
133,188
101,834
123,721
137,021
189,555
123,053
130,905
159,349
160,626
123,131
127,280
142,785
180,853
188,669
218,051
211,712
213,243
246,221
355,825
355,647
437,553
494,358
492,278
548,893
565,198
534,596
456,391
470,286
470,286456,391534,596565,198548,893492,278494,358437,553355,647355,825246,221213,243211,712218,051188,669180,853142,785127,280123,131160,626159,349130,905123,053189,555137,021123,721101,834133,188105,686146,915143,254130,500129,054184,227171,901147,387157,063213,810239,428295,538183,437262,480275,216197,233207,033190,461227,271182,811163,930185,293191,813203,143163,002228,732265,535230,041142,602180,234146,748129,318107,012197,854166,162105,41072,29981,86687,57293,51295,51683,34279,87076,62250,80552,34152,31486,44162,52151,78250,37252,43053,86863,56758,76359,00255,26243,44340,86443,98037,57523,69521,27528,452
       Other Current Liabilities 
23,392
56,334
16,686
36,898
21,052
18,217
12,145
41,938
24,402
47,133
26,445
37,089
34,372
29,833
28,072
43,706
51,794
47,779
47,305
55,991
59,935
63,126
80,656
37,327
44,667
21,250
39,379
41,595
44,532
43,037
43,325
44,418
43,416
54,068
60,709
59,751
56,923
51,633
55,487
63,146
50,436
48,361
51,590
54,497
43,035
44,292
64,201
115,149
97,011
61,327
91,521
67,387
48,348
36,539
44,509
89,858
90,362
56,689
44,625
80,088
45,657
52,302
53,866
78,137
55,998
62,197
88,500
96,771
80,210
56,104
54,163
70,987
481,000
29,000
29,000
120,425
117,609
79,897
97,126
115,185
108,503
97,138
169,743
139,261
139,978
534,224
675,444
10,000
3,953
593,298
4,754
5,520
5,5204,754593,2983,95310,000675,444534,224139,978139,261169,74397,138108,503115,18597,12679,897117,609120,42529,00029,000481,00070,98754,16356,10480,21096,77188,50062,19755,99878,13753,86652,30245,65780,08844,62556,68990,36289,85844,50936,53948,34867,38791,52161,32797,011115,14964,20144,29243,03554,49751,59048,36150,43663,14655,48751,63356,92359,75160,70954,06843,41644,41843,32543,03744,53241,59539,37921,25044,66737,32780,65663,12659,93555,99147,30547,77951,79443,70628,07229,83334,37237,08926,44547,13324,40241,93812,14518,21721,05236,89816,68656,33423,392
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,550
453,218
545,995
535,150
553,843
542,857
719,215
354,942
452,644
363,114
339,710
356,460
213,720
173,222
330,929
266,532
68,750
138,729
125,998
303,318
303,318125,998138,72968,750266,532330,929173,222213,720356,460339,710363,114452,644354,942719,215542,857553,843535,150545,995453,21844,550000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-541,000
-667,121
-640,050
-524,000
-574,900
0
0
0
0
41,450
41,210
39,578
23,555
20,505
30,225
29,584
28,810
37,240
35,599
26,093
19,286
19,28626,09335,59937,24028,81029,58430,22520,50523,55539,57841,21041,4500000-574,900-524,000-640,050-667,121-541,00000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
450,000
543,000
532,200
552,000
541,200
130,000
130,000
130,000
130,000
130,000
131,615
42,373
1,615
1,615
1,615
1,615
1,615
1,615
1,615
1,6151,6151,6151,6151,6151,6151,61542,373131,615130,000130,000130,000130,000130,000541,200552,000532,200543,000450,00040,000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,394
36,230
35,181
33,956
32,713
32,780
31,902
30,711
31,291
31,386
32,983
32,966
34,076
34,651
35,806
35,680
40,869
41,434
0
0
0
0
0
0000041,43440,86935,68035,80634,65134,07632,96632,98331,38631,29130,71131,90232,78032,71333,95635,18136,23054,394000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
412,016
404,387
420,388
416,523
422,007
422,304
423,270
428,120
431,742
433,740
433,639
441,035
441,130
442,102
443,310
456,413
460,636
462,079
468,523
472,916
474,893
479,373
480,500
486,228
492,270
499,846
503,652
518,635
521,293
531,288
535,780
541,803
544,537
555,297
561,926
571,950
576,706
583,119
589,744
592,415
594,991
601,645
599,899
605,166
608,878
614,131
615,554
625,365
630,103
639,271
1,028,839
1,044,810
1,049,232
1,045,974
1,043,613
1,064,430
1,476,948
1,477,022
1,477,254
1,480,729
1,482,022
1,482,552
1,482,880
1,484,744
1,486,345
1,487,044
1,487,536
1,489,800
1,491,880
1,487,206
1,490,090
1,388,625
1,338,703
1,309,762
1,306,464
1,309,259
1,346,656
1,337,437
1,420,779
1,453,415
1,687,999
1,689,661
1,621,640
1,660,509
1,746,193
1,660,987
1,564,284
1,570,417
1,553,379
1,418,872
1,450,960
1,578,494
1,578,4941,450,9601,418,8721,553,3791,570,4171,564,2841,660,9871,746,1931,660,5091,621,6401,689,6611,687,9991,453,4151,420,7791,337,4371,346,6561,309,2591,306,4641,309,7621,338,7031,388,6251,490,0901,487,2061,491,8801,489,8001,487,5361,487,0441,486,3451,484,7441,482,8801,482,5521,482,0221,480,7291,477,2541,477,0221,476,9481,064,4301,043,6131,045,9741,049,2321,044,8101,028,839639,271630,103625,365615,554614,131608,878605,166599,899601,645594,991592,415589,744583,119576,706571,950561,926555,297544,537541,803535,780531,288521,293518,635503,652499,846492,270486,228480,500479,373474,893472,916468,523462,079460,636456,413443,310442,102441,130441,035433,639433,740431,742428,120423,270422,304422,007416,523420,388404,387412,016
   Common Stock
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
136,145
288,390
288,390
288,390
288,390
288,390
288,390
288,390
317,230
317,230
317,230
317,230
317,230
317,230
317,230
317,230
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
412,398
496,609
496,609
496,609
496,609
496,609
496,609
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
573,886
0
573,886
0
0
0
000573,8860573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886573,886496,609496,609496,609496,609496,609496,609412,398412,398412,398412,398412,398412,398412,398412,398412,398412,398412,398412,398412,398317,230317,230317,230317,230317,230317,230317,230317,230288,390288,390288,390288,390288,390288,390288,390136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145136,145
   Retained Earnings 
41,609
26,610
39,139
29,437
34,921
35,218
35,456
38,188
41,972
43,947
44,300
50,319
51,802
53,848
54,031
63,466
68,308
70,055
76,735
77,439
80,179
84,481
87,586
93,525
92,522
100,098
103,904
114,972
117,630
98,787
103,278
106,965
109,699
120,459
127,089
134,236
138,992
113,682
120,307
120,679
123,255
129,909
128,163
132,922
136,634
141,887
143,310
151,992
156,730
165,898
172,081
185,735
239,359
236,101
233,739
254,557
249,644
250,668
250,900
254,375
255,668
256,198
256,526
258,390
259,991
260,690
261,182
263,518
265,597
260,542
263,425
142,460
124,123
137,456
144,155
207,859
245,257
236,038
237,359
235,161
262,024
253,334
254,451
232,147
234,477
201,085
200,550
186,548
201,784
148,278
169,684
230,105
230,105169,684148,278201,784186,548200,550201,085234,477232,147254,451253,334262,024235,161237,359236,038245,257207,859144,155137,456124,123142,460263,425260,542265,597263,518261,182260,690259,991258,390256,526256,198255,668254,375250,900250,668249,644254,557233,739236,101239,359185,735172,081165,898156,730151,992143,310141,887136,634132,922128,163129,909123,255120,679120,307113,682138,992134,236127,089120,459109,699106,965103,27898,787117,630114,972103,904100,09892,52293,52587,58684,48180,17977,43976,73570,05568,30863,46654,03153,84851,80250,31944,30043,94741,97238,18835,45635,21834,92129,43739,13926,61041,609
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,500
0
0
0
0
0
0
82,020
154,697
312,652
323,004
253,865
315,038
311,307
259,493
198,277
0
0
0
0
0
00000198,277259,493311,307315,038253,865323,004312,652154,69782,02000000019,50000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,069,909
Cost of Revenue-1,505,186
Gross Profit564,722564,722
 
Operating Income (+$)
Gross Profit564,722
Operating Expense-1,963,502
Operating Income106,407-1,398,780
 
Operating Expense (+$)
Research Development127,714
Selling General Administrative244,256
Selling And Marketing Expenses0
Operating Expense1,963,502371,971
 
Net Interest Income (+$)
Interest Income2,169
Interest Expense-51,797
Other Finance Cost-3,905
Net Interest Income-53,533
 
Pretax Income (+$)
Operating Income106,407
Net Interest Income-53,533
Other Non-Operating Income Expenses0
Income Before Tax (EBT)42,962106,407
EBIT - interestExpense = -51,797
43,557
95,354
Interest Expense51,797
Earnings Before Interest and Taxes (EBIT)094,759
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax42,962
Tax Provision--1,867
Net Income From Continuing Ops44,82944,829
Net Income43,557
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net053,533
 

Technical Analysis of Taloph
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Taloph. The general trend of Taloph is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Taloph's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Henan Taloph Pharmaceutical Stock Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.1 < 5.69 < 5.75.

The bearish price targets are: 4.59 > 3.75.

Tweet this
Henan Taloph Pharmaceutical Stock Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Henan Taloph Pharmaceutical Stock Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Henan Taloph Pharmaceutical Stock Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Henan Taloph Pharmaceutical Stock Co Ltd. The current macd is -0.06625305.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Taloph price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Taloph. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Taloph price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current adx is 19.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Taloph shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Henan Taloph Pharmaceutical Stock Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Henan Taloph Pharmaceutical Stock Co Ltd. The current sar is 5.36265415.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current rsi is 48.16. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Relative Strength Index (RSI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Henan Taloph Pharmaceutical Stock Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taloph price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Stochastic Oscillator ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current cci is -48.66562009.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Commodity Channel Index (CCI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Henan Taloph Pharmaceutical Stock Co Ltd. The current cmo is -2.82300305.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Henan Taloph Pharmaceutical Stock Co Ltd. The current willr is -60.34482759.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Taloph is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Henan Taloph Pharmaceutical Stock Co Ltd Daily Williams %R ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Henan Taloph Pharmaceutical Stock Co Ltd.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Henan Taloph Pharmaceutical Stock Co Ltd. The current atr is 0.24616071.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Average True Range (ATR) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Henan Taloph Pharmaceutical Stock Co Ltd. The current obv is 610,227,357.

Henan Taloph Pharmaceutical Stock Co Ltd Daily On-Balance Volume (OBV) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current mfi is 54.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Money Flow Index (MFI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Henan Taloph Pharmaceutical Stock Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Henan Taloph Pharmaceutical Stock Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.159
Ma 20Greater thanMa 505.169
Ma 50Greater thanMa 1005.031
Ma 100Greater thanMa 2005.503
OpenGreater thanClose4.950
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Taloph with someone you think should read this too:
  • Are you bullish or bearish on Taloph? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Taloph? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Henan Taloph Pharmaceutical Stock Co Ltd

I send you an email if I find something interesting about Henan Taloph Pharmaceutical Stock Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Henan Taloph Pharmaceutical Stock Co Ltd.

Receive notifications about Henan Taloph Pharmaceutical Stock Co Ltd in your mailbox!